Juan Harrison has moved from Takeda Ventures (TVI) to head up New Frontier Science (NFS), a new unit that aims to build relationships with academics and entrepreneurs developing disruptive ideas to improve patients' lives.

By creating centres of excellence around the world, J&J is expected to gain the flexibility and resources to invest from early to later stages and work with different types of entrepreneurs - whether from academia, venture capital-backed companies or incubating ideas internally.

Juan Harrison has moved from Takeda Ventures (TVI) to head up New Frontier Science (NFS), while Ilan Zipkin and Gordon Wong join.

Johnson & Johnson is setting up four innovation centres in California and Boston in the US, in the UK and in Shanghai, China.

This article features some of the notable points and soundbites from the 39 keynotes and panel discussions at the Global Corporate Venturing Symposium 2012. For the transcripts and slides (where available) of the presentations, please click on the links.

US-based healthcare companies Merck and Cleveland Clinic outline their strategies in these edited highlights from Global Corporate Venturing's symposium last month in London.

Venture firm Boston Millennia Partners's Patrick Fortune joins Cleveland Clinic Innovations.

Workers at Germany-based pharmaceutical company Merck Serono are reportedly campaigning for it to do more venture capital, as part of a protest about the shut down of its Swiss base.

The London-based institute is Intel's first research centre and hub looking at how technologies can improve the social and economic development of cities globally.